Latest Breaking News On - Aim leukemia - Page 7 : comparemela.com

Curis to Release Second Quarter 2022 Financial Results and Hold Conference Call on August 4, 2022

Curis to Release Second Quarter 2022 Financial Results and Hold Conference Call on August 4, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCraig westRoche groupDrug administrationInvestor relations corporate communicationscuris incCuris incAim lymphomaAim leukemiaOrphan drug designationTakeaim leukemiaTakeaim lymphomaInvestor relationsCorporate communicationscuris

Curis Announces Presentations on Biomarker Development and Emavusertib Clinical Data at the 2022 European Hematology Association (EHA) Hybrid Congress

Curis Announces Presentations on Biomarker Development and Emavusertib Clinical Data at the 2022 European Hematology Association (EHA) Hybrid Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJames dentzerDuane mitchellAmerican society of clinical oncologyDrug administrationUniversity of floridaEuropean hematology associationCuris incExchange commissionPrnewswire curis incRoche groupTakeaim leukemiaTakeaim lymphomaHematology associationHybrid congressChief executive officer

Curis Announces Encouraging Emavusertib Data at the 2022 American Society of Clinical Oncology Annual Meeting (ASCO)

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.

United statesRobert martellGrzegorz nowakowskiJames dentzerDuane mitchellGuillermo garcia maneroHead of researchAmerican society of clinical oncologyUniversity of texas md anderson cancer centerDrug administrationUniversity of floridaWashington university school of medicineCuris incWashington universityPrnewswire curis incDepartment of leukemia

Curis (CRIS) Reports Encouraging Emavusertib Data

Curis (CRIS) Reports Encouraging Emavusertib Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobert martellGrzegorz nowakowskiJames dentzerDuane mitchellGuillermo garcia maneroHead of researchAmerican society of clinical oncologyUniversity of texas md anderson cancer centerUniversity of floridaWashington university school of medicineCuris incWashington universityDepartment of leukemiaDivision of hematologyTakeaim lymphoma

Curis to Present at 2022 Jefferies Global Healthcare Conference

/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.

New yorkUnited statesJames dentzerPrnewswire curis incRoche groupDrug administrationCuris incChief executive officerHealthcare conferenceAim lymphomaAim leukemiaOrphan drug designationTakeaim leukemiaTakeaim lymphoma